Shareholder Structure
The data shown was taken in each case from the latest announcement communicated by the shareholder.
| Ordinary Shares: | ||
| Release according to § 33 Abs. 1 WpHG:** | ||
| 96.20% | Grifols S.A.* | |
| 0.13% | Polygon Global Partners LLP | |
| 0.07% | UBS Group AG | |
| *: On 2 May 2022, Grifols, S.A. published in accordance with sec. 23 para. 2 sentence 1 WpÜG, that Grifols, S.A. acquired further 0.94 % of the voting rights in Biotest AG. Therefore, Grifols, S.A. holds 97.14 % of the voting right in Biotest AG. ** On 6 June 2025, Grifols Biotest Holding GmbH announced in its final announcement that a further 2.1072% of Biotest ordinary shares had been accepted. Grifols S.A. now holds a total of 99.25% of the voting rights in Biotest AG. |
||
| Preference Shares: | ||
| 100.00% | Free float | |